Thalia Therapeutics Plc Profit Margin

Thalia Therapeutics Plc (THAT.L) currently reports a profit margin of -17952.81% as of June 2026. That compares with -34184.45% in the prior-year period — up 47.5% year over year. That is below the Healthcare sector average of 10.58%. Use the charts on this page to explore Thalia Therapeutics Plc's profit margin history and peer comparisons.

Thalia Therapeutics Plc's profit margin increased from -34184.45% to -17952.81% — a 47.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Thalia Therapeutics Plc's profit margin of -17952.81% is lower than the Healthcare sector average of 10.58%. That is roughly 169778.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Thalia Therapeutics Plc's current -17952.81% should be judged against Healthcare norms (sector average: 10.58%) and against THAT.L's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -17952.81%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for Thalia Therapeutics Plc, and consider following THAT.L for alerts when major investors trade the stock.